In another long-term, double-blind, managed research32 of escitalopram (20 mg/day) versus duloxetine (60 mg/day) for 24 weeks, the full total MADRS rating improved significantly to a larger extent within the escitalopram group than in the duloxetine group at a week

In another long-term, double-blind, managed research32 of escitalopram (20 mg/day) versus duloxetine (60 mg/day) for 24 weeks, the full total MADRS rating improved significantly to a larger extent within the escitalopram group than in the duloxetine group at a week. … Continue reading In another long-term, double-blind, managed research32 of escitalopram (20 mg/day) versus duloxetine (60 mg/day) for 24 weeks, the full total MADRS rating improved significantly to a larger extent within the escitalopram group than in the duloxetine group at a week